Angiodynamics (ANGO) Share-based Compensation (2010 - 2026)
Angiodynamics' (ANGO) quarterly Share-based Compensation came in at $3.9 million in Q2 2026, up 138.57% YoY from $1.6 million in Q2 2025, and up 45.86% on a QoQ basis from $2.7 million in Q1 2026.
Angiodynamics (ANGO) Share-based Compensation (2010 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 17 years of Share-based Compensation data on file, last reported at $3.9 million in Q2 2026.
- Quarterly Share-based Compensation rose 138.57% year-over-year to $3.9 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $14.0 million (up 42.86% YoY) and the FY2026 annual result came in at $14.0 million, up 42.86% from the prior year.
- Share-based Compensation rose to $3.9 million in Q2 2026, from $2.7 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $4.5 million in Q3 2025 to a low of $1.6 million in Q2 2025.
- A 5-year average of $2.8 million and a median of $2.8 million in 2025 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2023 — Share-based Compensation tumbled 43.97% — and 2026, when it soared 138.57%.
- Tracing ANGO's Share-based Compensation over 5 years: stood at $3.4 million in 2022, then sank by 43.97% to $1.9 million in 2023, then surged by 34.68% to $2.5 million in 2024, then gained by 14.36% to $2.9 million in 2025, then surged by 35.42% to $3.9 million in 2026.
- The last three Share-based Compensation figures came in at $3.9 million (Q2 2026), $2.7 million (Q1 2026), and $2.9 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 67.10 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 55.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 42.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 27.46 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 38.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 33.00 Mn |
| 10 | Angiodynamics | 658.19 Mn | 604.32 Mn | 46.77 Mn | 3.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 3.92 Mn |
| May 31, 2026 | 3.92 Mn |
| Feb 28, 2026 | 2.68 Mn |
| Feb 28, 2026 | 2.68 Mn |
| Nov 30, 2025 | 2.89 Mn |
| Nov 30, 2025 | 2.89 Mn |
| Aug 31, 2025 | 4.47 Mn |
| Aug 31, 2025 | 4.47 Mn |
| May 31, 2025 | 1.64 Mn |
| May 31, 2025 | 1.64 Mn |
| Feb 28, 2025 | 2.40 Mn |
| Feb 28, 2025 | 2.40 Mn |
| Nov 30, 2024 | 2.53 Mn |
| Nov 30, 2024 | 2.53 Mn |
| Aug 31, 2024 | 3.21 Mn |
| Aug 31, 2024 | 3.21 Mn |
| May 31, 2024 | 1.90 Mn |
| May 31, 2024 | 1.90 Mn |
| Feb 29, 2024 | 2.61 Mn |
| Feb 29, 2024 | 2.61 Mn |